Targets and molecular mechanisms of triptolide in cancer therapy

Chinese Journal of Cancer Research

Volumn 26, Issue 5, 2014, Pages 622-626

  Meng, Cuicui ^a   Zhu, Hongcheng ^b   Song, Hongmei ^a   Wang, Zhongming ^c   Huang, Guanhong ^c   Li, Defan ^c   Ma, Zhaoming ^c   Ma, Jianhua ^c   Qin, Qin ^b   Sun, Xinchen ^b   Ma, Jianxin ^c  

^a BENGBU MEDICAL COLLEGE   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c Lianyungang No 2 People's Hospital   (China)

Author keywords

Antineoplastic; Cancer; Neoplasms; Triptolide (TPL TL)

Indexed keywords

CARBOPLATIN; CASPASE; CISPLATIN; DEXAMETHASONE; DNA; FLUOROURACIL; HEAT SHOCK PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OXALIPLATIN; TRIPTOLIDE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER THERAPY; CELL PROLIFERATION; DRUG MECHANISM; DRUG TARGETING; HUMAN; METASTASIS; NEOPLASM; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); REVIEW; SIGNAL TRANSDUCTION;

EID: 84937440147     PISSN: 10009604     EISSN: 19930631     Source Type: Journal    
DOI: 10.3978/j.issn.1000-9604.2014.09.01     Document Type: Review

References (34)

1. Yang S, Chen J, Guo Z, et al. Triptolide inhibits the growth and metastasis of solid tumors. Mol Cancer Ther 2003;2:65-72.
2. Hung FM, Chen YL, Huang AC, et al. Triptolide induces S phase arrest via the inhibition of cyclin E and CDC25A and triggers apoptosis via caspase- and mitochondrial-dependent signaling pathways in A375.S2 human melanoma cells. Oncol Rep 2013;29:1053-60.
3. Johnson SM, Wang X, Evers BM. Triptolide inhibits proliferation and migration of colon cancer cells by inhibition of cell cycle regulators and cytokine receptors. J Surg Res 2011;168:197-205.
4. Wu J, Li QQ, Zhou H, et al. Selective tumor cell killing by triptolide in p53 wild-type and p53 mutant ovarian carcinomas. Med Oncol 2014;31:14.
5. Hu YP, Tan ZJ, Wu XS, et al. Triptolide induces s phase arrest and apoptosis in gallbladder cancer cells. Molecules 2014;19:2612-28.
6. Wang XF, Zhao YB, Wu Q, et al. Triptolide induces apoptosis in endometrial cancer via a p53‑independent mitochondrial pathway. Mol Med Rep 2014;9:39-44.
7. Nakazato T, Sagawa M, Kizaki M. Triptolide induces apoptotic cell death of multiple myeloma cells via transcriptional repression of Mcl-1. Int J Oncol 2014;44:1131-8.
8. Ding X, Zhang B, Pei Q, et al. Triptolide induces apoptotic cell death of human cholangiocarcinoma cells through inhibition of myeloid cell leukemia-1. BMC Cancer 2014;14:271.
9. Guo Q, Nan XX, Yang JR, et al. Triptolide inhibits the multidrug resistance in prostate cancer cells via the downregulation of MDR1 expression. Neoplasma 2013;60:598-604.
10. Tan BJ, Chiu GN. Role of oxidative stress, endoplasmic reticulum stress and ERK activation in triptolide-induced apoptosis. Int J Oncol 2013;42:1605-12.
11. Zhu W, Li J, Wu S, et al. Triptolide cooperates with Cisplatin to induce apoptosis in gemcitabine-resistant pancreatic cancer. Pancreas 2012;41:1029-38.
12. Westerheide SD, Kawahara TL, Orton K, et al. Triptolide, an inhibitor of the human heat shockresponse that enhances stress-induced cell death. J Biol Chem 2006;281:9616-22. Erratum in: J Biol Chem 2006;281:21575.
13. Banerjee S, Sangwan V, McGinn O, et al. Triptolide-induced cell death in pancreatic cancer is mediated by O-GlcNAc modification of transcription factor Sp1. J Biol Chem 2013;288:33927-38.
14. Park SW, Kim YI. Triptolide induces apoptosis of PMA-treated THP-1 cells through activation of caspases, inhibition of NF-κB and activation of MAPKs. Int J Oncol 2013;43:1169-75.
15. Li M, Wang X, Liu M, et al. NF-κB signaling inhibition and anticancer activities of LLDT-246 on human colorectal cancer HCT-116 cells in vitro. Biomed Pharmacother 2014;68:527-35.
16. Ou CC, Chen YW, Hsu SC, et al. Triptolide Transcriptionally Represses HER2 in Ovarian Cancer Cells by Targeting NF-κB. Evid Based Complement Alternat Med 2012;2012:350239.
17. Zhong YY, Chen HP, Tan BZ, et al. Triptolide avoids cisplatin resistance and induces apoptosis via the reactive oxygen species/nuclear factor-κB pathway in SKOV3PT platinum-resistant human ovarian cancer cells. Oncol Lett 2013;6:1084-92.
18. Zhu W, Hu H, Qiu P, et al. Triptolide induces apoptosis in human anaplastic thyroid carcinoma cells by a p53-independent but NF-kappaB-related mechanism. Oncol Rep 2009;22:1397-401.
19. Keogh MC, Kim JA, Downey M, et al. A phosphatase complex that dephosphorylates gammaH2AX regulates DNA damage checkpoint recovery. Nature 2006;439:497-501.
20. Chueh FS, Chen YL, Hsu SC, et al. Triptolide induced DNA damage in A375.S2 human malignant melanoma cells is mediated via reduction of DNA repair genes. Oncol Rep 2013;29:613-8.
21. Owa C, Messina ME Jr, Halaby R. Triptolide induces lysosomal-mediated programmed cell death in MCF-7 breast cancer cells. Int J Womens Health 2013;5:557-69.
22. He MF, Huang YH, Wu LW, et al. Triptolide functions as a potent angiogenesis inhibitor. Int J Cancer 2010;126:266-78.
23. Ma JX, Sun YL, Wang YQ, et al. Triptolide induces apoptosis and inhibits the growth and angiogenesis of human pancreatic cancer cells by downregulating COX-2 and VEGF. Oncol Res 2013;20:359-68.
24. Li Y, Hu S. Triptolide sensitizes liver cancer cell lines to chemotherapy in vitro and in vivo. Panminerva Med 2014;56:211-20.
25. Westfall SD, Nilsson EE, Skinner MK. Role of triptolide as an adjunct chemotherapy for ovarian cancer. Chemotherapy 2008;54:67-76.
26. Alsaied OA, Sangwan V, Banerjee S, et al. Sorafenib and triptolide as combination therapy for hepatocellular carcinoma. Surgery 2014;156:270-9.
27. Liu Y, Xiao E, Yuan L, et al. Triptolide synergistically enhances antitumor activity of oxaliplatin in colon carcinoma in vitro and in vivo. DNA Cell Biol 2014;33:418-25.
28. Sai K, Li WY, Chen YS, et al. Triptolide synergistically enhances temozolomide-induced apoptosis and potentiates inhibition of NF-κB signaling in glioma initiating cells. Am J Chin Med 2014;42:485-503.
29. Huang X, Yang M, Jin J. Triptolide enhances the sensitivity of multiple myeloma cells to dexamethasone via microRNAs. Leuk Lymphoma 2012;53:1188-95.
30. Liu Y, Chen F, Wang S, et al. Low-dose triptolide in combination with idarubicin induces apoptosis in AML leukemic stem-like KG1a cell line by modulation of the intrinsic and extrinsic factors. Cell Death Dis 2013;4:e948.
31. Chen RH, Tian YJ. Enhanced anti-tumor efficacy of aspirin combined with triptolide in cervical cancer cells. Asian Pac J Cancer Prev 2013;14:3041-4.
32. Wang W, Yang S, Su Y, et al. Enhanced antitumor effect of combined triptolide and ionizing radiation. Clin Cancer Res 2007;13:4891-9.
33. Chen YW, Lin GJ, Hueng DY, et al. Enhanced anti-tumor activity of triptolide in combination with irradiation for the treatment of oral cancer. Planta Med 2014;80:255-61.
34. Kitzen JJ, de Jonge MJ, Lamers CH, et al. Phase I dose-escalation study of F60008, a novel apoptosis inducer, in patients with advanced solid tumours. Eur J Cancer 2009;45:1764-72.